Form 4 for MGNX MACROGENICS INC
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0001125345-25-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 | 2025-02-08 | MGNX | Smith Beth Ann | VP, Ctrl, Treas | F - Tax | $2.60 | -612 | 8,860 | -6% | -$1,591 |
| D | 2025-02-11 | 2025-02-08 | MGNX | Smith Beth Ann | VP, Ctrl, Treas | M - OptEx | — | +1,583 | 9,472 | +20% | — |
| D | 2025-02-11 | 2025-02-08 | MGNX | Smith Beth Ann | VP, Ctrl, Treas | M - OptEx | $0.00 | -1,583 | 3,167 | -33% | $0 |
| DM | 2025-02-11 | 2025-02-07 | MGNX | Smith Beth Ann | VP, Ctrl, Treas | A - Grant | $0.00 | +54.9K | 47.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-08 | F | D | 612 | $2.60 | 8,860 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-08 | M | A | 1,583 | — | 9,472 | D | — | — | (F1) On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Unit | 2025-02-08 | M | D | 1,583 | $0.00 | 3,167 | D | $0.00 · — to — | 1,583 Common Stock | (F1) On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| 4 | Derivative | Restricted Stock Unit | 2025-02-07 | A | A | 7,850 | $0.00 | 7,850 | D | — · — to — | 7,850 Common Stock | (F3) Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2025-02-07 | A | A | 47,050 | $0.00 | 47,050 | D | $2.60 · — to 2035-02-07 | 47,050 Common Stock | (F2) 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. |